Differential Suppression of Human Cervical Cancer Cell Growth by Adenovirus Delivery of p53in vitro: Arrest Phase of Cell Cycle Is Dependent on Cell Line
- 1 September 2002
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 93 (9) , 1012-1019
- https://doi.org/10.1111/j.1349-7006.2002.tb02478.x
Abstract
It has been reported that overexpression of wild‐type p53 protein induces suppression of tumor cell growth in vivo and in vitro. In this study, we further evaluated the differential effects of p53 delivered in an adenovirus vector on the cell growth, apoptosis and cell cycle progression in cervical cancer cell lines. We constructed a recombinant adenovirus expressing p53 and then delivered this into cervical carcinoma cell lines (CaSki, SiHa, and HeLa, HeLaS3) along with adenovirus expressing β‐galactosidase as a negative control. Adenovirus‐delivered p53 overexpression resulted in a more significant suppression of cell growth in HPV 18‐infected cells (HeLa and HeLaS3) and a lesser suppression in HPV 16‐infected cells (CaSki and SiHa). However, no suppression was observed in cells infected with a negative control virus. p53 overexpression also induced apoptosis and cell cycle arrest, as determined by annexin V and propidium iodide staining. In particular, the cell cycle was arrested in the G2/M phase in CaSki cells. In contrast, cell cycles were arrested in the G1 phase in HeLa cells, suggesting that the arrest phase is dependent upon the cervical cancer cell line. Taken together, these data support the idea that overexpressed p53 protein plays a differential role in suppressing cervical cancer cell growth through apoptosis and cell cycle arrest in either G1 or G2/M phase, depending on the cancer cell line.Keywords
This publication has 35 references indexed in Scilit:
- Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblastsInternational Journal of Radiation Biology, 2001
- Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53Cancer Gene Therapy, 2000
- Overexpression of the wild-type p53 gene inhibits NF-κB activity and synergizes with aspirin to induce apoptosis in human colon cancer cellsOncogene, 2000
- HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6Oncogene, 1999
- Adenovirus-Mediated p53 Growth Inhibition of Ovarian Cancer Cells Is Independent of Endogenous p53 StatusGynecologic Oncology, 1999
- The cellular response to p53: the decision between life and deathOncogene, 1999
- Mdm2 binds p73α without targeting degradationOncogene, 1999
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Oncoproteins Encoded by the Cancer-associated Human Papillomaviruses Target the Products of the Retinoblastoma and p53 Tumor Suppressor GenesCold Spring Harbor Symposia on Quantitative Biology, 1991
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990